Fonte: European Journal of Pain. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
CAMARGO, E. A. et al. Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2. European Journal of Pain, v. 18, n. 5, p. 691-700, 2014Tradução . . Disponível em: https://doi.org/10.1002/j.1532-2149.2013.00414.x. Acesso em: 01 nov. 2024.APA
Camargo, E. A., Santana, D. G., Silva, C. I., Teixeira, S. A., Toyama, M. H., Cotrim, C., et al. (2014). Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2. European Journal of Pain, 18( 5), 691-700. doi:10.1002/j.1532-2149.2013.00414.xNLM
Camargo EA, Santana DG, Silva CI, Teixeira SA, Toyama MH, Cotrim C, Landucci ECT, Antunes E, Muscará MN, Costa SKP. Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2 [Internet]. European Journal of Pain. 2014 ; 18( 5): 691-700.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/j.1532-2149.2013.00414.xVancouver
Camargo EA, Santana DG, Silva CI, Teixeira SA, Toyama MH, Cotrim C, Landucci ECT, Antunes E, Muscará MN, Costa SKP. Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2 [Internet]. European Journal of Pain. 2014 ; 18( 5): 691-700.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/j.1532-2149.2013.00414.x